Autonomic nervous system dysfunction in Parkinson's disease: relationships with age, medication, duration, and severity
- PMID: 8410008
- PMCID: PMC1015238
- DOI: 10.1136/jnnp.56.10.1090
Autonomic nervous system dysfunction in Parkinson's disease: relationships with age, medication, duration, and severity
Abstract
Heart rate variability at rest, during deep breathing, or standing up and with the Valsalva manoeuvre did not differ significantly between 67 patients with idiopathic Parkinson's disease (PD) and 31 healthy age matched controls. Blood pressure (BP) responses to standing up and sustained handgrip revealed diminished autonomic function in the PD group. In a preliminary analysis of the PD group older age, anti-Parkinson medication and higher Hoehn and Yahr (HY) stages were each associated with poor autonomic responsiveness. Disease duration was only related to the systolic BP fall on standing up. Multiple stepwise regression analysis showed that older age explained most of the variance of heart rate variability (up to 36%), and the only significant PD related factor was the use of medication, which explained less than 7%. The HY stage accounted for 12.7% of the variance in the standing up BP test, and the use of medication explained 10.6% of the variance of the systolic BP change in the sustained hand grip test. The unmedicated PD subgroup (n = 33), who had mild disease of short duration, showed no evidence of autonomic dysfunction. Cardiovascular autonomic dysfunction in PD is mild, mainly affects blood pressure responses, and occurs only in advanced cases.
Similar articles
-
Frequency and predictors of autonomic dysfunction in Parkinson's disease: a study of African patients in Lagos, Nigeria.Niger Postgrad Med J. 2004 Mar;11(1):45-9. Niger Postgrad Med J. 2004. PMID: 15254572
-
Autonomic dysfunction according to disease progression in Parkinson's disease.Parkinsonism Relat Disord. 2014 Mar;20(3):303-7. doi: 10.1016/j.parkreldis.2013.12.001. Epub 2013 Dec 16. Parkinsonism Relat Disord. 2014. PMID: 24382402
-
Autonomic Function Tests and MIBG in Parkinson's Disease: Correlation to Disease Duration and Motor Symptoms.CNS Neurosci Ther. 2015 Sep;21(9):727-32. doi: 10.1111/cns.12437. Epub 2015 Jul 24. CNS Neurosci Ther. 2015. PMID: 26205884 Free PMC article.
-
[Disorders of autonomic regulation in Parkinson syndrome].Fortschr Neurol Psychiatr. 1995 May;63(5):194-205. doi: 10.1055/s-2007-996616. Fortschr Neurol Psychiatr. 1995. PMID: 7782020 Review. German.
-
Managing autonomic dysfunction in Parkinson's disease: a review of emerging drugs.Expert Opin Emerg Drugs. 2020 Mar;25(1):37-47. doi: 10.1080/14728214.2020.1729120. Epub 2020 Feb 20. Expert Opin Emerg Drugs. 2020. PMID: 32067502 Review.
Cited by
-
Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study.Osteoporos Int. 2011 Jul;22(7):2197-204. doi: 10.1007/s00198-010-1455-3. Epub 2010 Oct 22. Osteoporos Int. 2011. PMID: 20967420 Free PMC article.
-
Autonomic and electrocardiographic findings in Parkinson's disease.Auton Neurosci. 2017 Jul;205:93-98. doi: 10.1016/j.autneu.2017.04.002. Epub 2017 Apr 14. Auton Neurosci. 2017. PMID: 28506500 Free PMC article.
-
Age and duration related changes in muscle sympathetic nerve activity in Parkinson's disease.J Neurol Neurosurg Psychiatry. 2003 Oct;74(10):1407-11. doi: 10.1136/jnnp.74.10.1407. J Neurol Neurosurg Psychiatry. 2003. PMID: 14570835 Free PMC article.
-
Determinants of autonomic dysfunction in idiopathic Parkinson's disease.J Neurol. 2005 Dec;252(12):1530-6. doi: 10.1007/s00415-005-0909-6. J Neurol. 2005. PMID: 16362830
-
Suppressed sympathetic skin response in Parkinson disease.Clin Auton Res. 2000 Dec;10(6):337-42. doi: 10.1007/BF02322257. Clin Auton Res. 2000. PMID: 11324989 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical